mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
0.22 |
6e-05 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
6e-05 |
mRNA |
N9-isopropylolomoucine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
mRNA |
AZD0530 |
CCLE |
pan-cancer |
AAC |
0.2 |
0.0003 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |
mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
0.0004 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0006 |
mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
0.0006 |
mRNA |
FR-180204 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
0.0006 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0006 |